Mendelian susceptibility to mycobacterial diseases due to complete ISG15 deficiency is a rare genetic condition that weakens a person’s ability to fight certain infections. People with this condition often have severe or unusual infections from weak mycobacteria, like BCG after vaccination or environmental mycobacteria, and can also have frequent viral illnesses. Signs usually begin in infancy or early childhood and tend to be lifelong, but severity can vary between families. Treatment focuses on prompt, targeted antibiotics for mycobacterial infections and careful prevention and monitoring, and some may benefit from interferon-gamma–based approaches under specialist care. The outlook depends on infection control and access to care, and many living with Mendelian susceptibility to mycobacterial diseases due to complete ISG15 deficiency can do well with early diagnosis and expert management.
Overview
Mendelian susceptibility to mycobacterial diseases due to complete isg15 deficiencySymptoms
Mendelian susceptibility to mycobacterial diseases due to complete ISG15 deficiency usually appears in infancy or early childhood, often after BCG vaccination. Features include recurrent or severe mycobacterial infections with high fevers, swollen lymph nodes, pneumonia, and skin or bone infections.
Outlook and prognosis
Most people with Mendelian susceptibility to mycobacterial diseases due to complete ISG15 deficiency can do well with early diagnosis, prompt antibiotics, and careful infection prevention. Severe infections may occur, especially after certain live vaccines or environmental exposure, so specialist follow‑up matters. Outcomes vary, but many achieve good long‑term health with tailored care.
Causes and risk factors
Mendelian susceptibility to mycobacterial diseases due to complete ISG15 deficiency is caused by autosomal recessive ISG15 mutations in both copies, present from birth. Risk rises with family history, consanguinity, BCG at birth, and higher mycobacterial exposure; early symptoms prompt evaluation.
Genetic influences
Genetics are central in this condition; complete ISG15 deficiency is an inherited, single-gene cause. Variants disrupt immune signaling against mycobacteria, driving vulnerability and shaping severity. Family history informs risk, and genetic testing confirms diagnosis and guides counseling.
Diagnosis
Clinicians suspect it from severe or recurrent mycobacterial infections and immune tests. Confirmation comes from genetic testing showing ISG15 variants and interferon-gamma studies. These establish the genetic diagnosis of Mendelian susceptibility to mycobacterial diseases due to complete isg15 deficiency.
Treatment and drugs
Treatment focuses on quickly treating mycobacterial infections and preventing new ones. Doctors often use multi‑drug antibiotics, consider interferon‑gamma in selected cases, and give tailored vaccines and infection‑avoidance guidance. Care is coordinated by immunology and infectious disease specialists.
Symptoms
Many families first notice issues after a routine BCG vaccine or a seemingly minor mycobacterial exposure. Early features of Mendelian susceptibility to mycobacterial diseases due to complete ISG15 deficiency often include stubborn fevers, swollen glands, or infections that don’t clear as expected. Features vary from person to person and can change over time. Some people have only localized problems, while others develop widespread infection that affects several organs.
After BCG vaccination, a large sore at the injection site, persistent swollen nodes, or fever can last weeks. It can spread beyond the arm, which is a hallmark issue in Mendelian susceptibility to mycobacterial diseases due to complete ISG15 deficiency.
High fevers (often over 38.5°C/101°F) that return or last for days are common during active infection. They may improve with antibiotics but flare again when treatment stops.
Firm, tender lumps in the neck, armpit, or groin may appear and sometimes drain pus. This often follows mycobacterial exposure in Mendelian susceptibility to mycobacterial diseases due to complete ISG15 deficiency.
A deep or long-lasting cough, chest discomfort, or shortness of breath may point to lung infection. In Mendelian susceptibility to mycobacterial diseases due to complete ISG15 deficiency, the lungs are a common site of infection.
How people usually first notice Mendelian susceptibility to mycobacterial diseases due to complete isg15 deficiency?
Many families first notice something is off when a baby or young child has unusually severe infections after routine Bacille Calmette–Guérin (BCG) vaccination or exposure to environmental mycobacteria, with high fevers, swollen lymph nodes, or abscesses that don’t heal as expected. Doctors may also see frequent or severe viral illnesses, especially from herpesviruses, alongside poor weight gain or prolonged recovery from common infections, which raises concern for an inborn immune system problem. These patterns are often the first signs of Mendelian susceptibility to mycobacterial diseases due to complete ISG15 deficiency and prompt referral to an immunology specialist for testing.
Types of Mendelian susceptibility to mycobacterial diseases due to complete isg15 deficiency
Mendelian susceptibility to mycobacterial diseases due to complete ISG15 deficiency is a rare inherited immune condition. Different variants or subtypes aren’t typically used; instead, clinicians recognize a single genetic defect with a spectrum of severity. People with this condition often share core features, but the timing and intensity can differ depending on infections they encounter, age, and access to treatment. Not everyone will experience every type of infection or inflammation in the same way.
No recognized subtypes
There are no widely accepted types of Mendelian susceptibility to mycobacterial diseases due to complete ISG15 deficiency. Clinicians describe one genetic disorder with variable severity rather than distinct variants. This means guides about types of Mendelian susceptibility to mycobacterial diseases due to complete ISG15 deficiency focus on presentation differences, not formal subtypes.
What genetics can tell you about symptoms
People with complete ISG15 deficiency often have repeated infections from weak mycobacteria (like BCG vaccine strains) and skin, lung, or lymph node inflammation, because their immune cells can’t switch on interferon responses properly. Some also develop brain inflammation after live vaccines due to uncontrolled immune signaling.
Causes and risk factors
It is caused by inherited changes in both copies of the ISG15 gene, often passed down by healthy carrier parents. Key risk factors for infections in Mendelian susceptibility to mycobacterial diseases due to complete isg15 deficiency are exposure to BCG vaccine strains, environmental mycobacteria, or tuberculosis. Genes set the stage, but environment and lifestyle often decide how the story unfolds. Crowded indoor settings, close contact with active TB, and living or traveling in high incidence regions increase exposure risk. Being very young, undernutrition, or other illnesses that weaken immunity can worsen outcomes, while good nutrition and quick medical care can help reduce complications.
Environmental and biological risk factors
Understanding what raises the chance of being born with Mendelian susceptibility to mycobacterial diseases due to complete ISG15 deficiency can help families focus on what’s known and what isn’t. Doctors often group risks into internal (biological) and external (environmental). For this rare, birth‑onset condition, the likelihood mostly reflects biology at the time of conception, and only a few external exposures have any proven role. Here are environmental and biological risk factors for Mendelian susceptibility to mycobacterial diseases due to complete ISG15 deficiency as currently understood.
Sperm from older fathers has a slightly higher rate of new DNA changes. This can very rarely raise the chance of a child having a rare condition present from birth. The absolute risk for this specific condition remains very low.
Egg cells from older mothers also show a small rise in new DNA changes. While age is better known for chromosome differences, it can occasionally contribute to rare single‑gene conditions at conception. The overall chance of this condition from maternal age alone is still low.
When parents are closely related by blood, they are more likely to share the same rare changes. This raises the likelihood of conditions that require matching changes from each side of the family line. This pattern has been observed across several rare, birth‑onset conditions.
There are no well‑established everyday environmental exposures linked to a higher chance of Mendelian susceptibility to mycobacterial diseases due to complete ISG15 deficiency. Typical community exposures, such as ambient air pollution, have not been shown to cause this condition.
Genetic risk factors
Inherited changes in the ISG15 gene are the main driver of this condition’s risk of serious infection with mycobacterial germs. Some risk factors are inherited through our genes. When both copies of ISG15 do not work, this leads to Mendelian susceptibility to mycobacterial diseases due to complete ISG15 deficiency.
ISG15 gene changes: Harmful changes in the ISG15 gene stop the body from making a working ISG15 protein. Without it, immune cells make too little interferon-gamma, a key signal against mycobacterial germs. This helps explain why early symptoms of Mendelian susceptibility to mycobacterial diseases due to complete ISG15 deficiency can appear in infancy.
Autosomal recessive: The condition appears when someone inherits two nonworking ISG15 copies, one from each parent. Carriers with one changed copy typically stay healthy but can pass it on. Each child of two carriers has a 25% (1 in 4) chance to be affected.
Complete loss needed: Susceptibility is linked to complete loss of ISG15 function on both gene copies. Changes that leave some function may not cause the same mycobacterial risk. Lab reports may describe these as loss-of-function variants.
Family and ancestry: Having an affected sibling or known ISG15 changes in the family raises the chance that others carry the same variant. Risk is higher when parents are related by blood, because the same change can be inherited from both sides. Some communities have a more common older variant, which can cluster cases.
Variable severity: Even with the same ISG15 changes, the age at first infection and overall severity can differ. This variation can occur even within the same family.
Pathway specifics: ISG15 also works outside cells to boost interferon-gamma release, so its absence weakens this defense against mycobacteria. This mechanism underlies Mendelian susceptibility to mycobacterial diseases due to complete ISG15 deficiency.
Lifestyle risk factors
This is a genetic immune condition; lifestyle habits do not cause it. However, how lifestyle affects Mendelian susceptibility to mycobacterial diseases due to complete isg15 deficiency can influence infection risk, severity, and recovery. Behaviors that support lung and immune health, reduce exposure to live mycobacterial sources, and improve treatment adherence are most relevant.
Avoiding live mycobacterial vaccines (like BCG) is important because ISG15 deficiency impairs the IFN-γ pathway needed to control these organisms. Discuss vaccine plans with your clinician to prevent triggering disseminated mycobacterial disease.
Protein- and calorie-adequate diets support macrophage and T-cell function that compensate for ISG15-related immune gaps. Malnutrition can worsen the course of mycobacterial infections and slow recovery.
Low vitamin D is linked to higher mycobacterial susceptibility and slower clearance. Maintaining adequate levels may support antimycobacterial immunity alongside medical therapy.
Tobacco or vaping damages airway defenses and macrophage function, increasing risk of nontuberculous mycobacterial lung disease in ISG15 deficiency. Stopping reduces pulmonary infections and complications.
Risk prevention
Mendelian susceptibility to mycobacterial diseases due to complete ISG15 deficiency is a genetic condition, so the focus is on preventing infections and complications rather than the condition itself. The goal is to lower exposure to mycobacteria, keep vaccinations tailored and up to date, and act quickly if symptoms start. Prevention is about lowering risk, not eliminating it completely. Work with an immunology or infectious-disease specialist to personalize your plan over time.
People with ISG15 deficiency should not receive the BCG vaccine or other live mycobacterial vaccines. Discuss TB prevention strategies and alternatives with your care team.
Stay current with inactivated vaccines like influenza and pneumococcal shots. Live vaccines should be reviewed case by case by a specialist familiar with ISG15 deficiency.
Wash hands often and avoid untreated water or poorly maintained hot tubs that can carry nontuberculous mycobacteria. Consider masks and good ventilation in crowded clinics or during TB outbreaks.
Ask close contacts to be screened and treated for latent TB if needed. Reducing TB in the home lowers exposure for someone living with ISG15 deficiency.
Transmission
Mendelian susceptibility to mycobacterial diseases due to complete ISG15 deficiency is an inherited immune condition, not something you can catch from someone else. It follows an autosomal recessive pattern: a child is affected only if they receive two nonworking copies of the ISG15 gene, one from each parent, who are usually healthy carriers.
When both parents are carriers, each pregnancy has a 25% (1 in 4) chance for a child to have the condition, a 50% (1 in 2) chance the child will be a carrier, and a 25% (1 in 4) chance the child will inherit two working copies. Genetic transmission of Mendelian susceptibility to mycobacterial diseases due to complete ISG15 deficiency most often involves two carrier parents; very rarely, a child may have it because of a new gene change that was not inherited. The condition itself isn’t contagious, but some infections people living with it may develop—such as tuberculosis—can spread to others, so standard public health precautions still apply.
When to test your genes
Genetic testing is reasonable if you or close relatives have severe, unusual, or recurrent infections from weak mycobacteria (like BCG vaccine or environmental mycobacteria), especially in childhood. People from families with known ISG15 variants or unexplained interferon‑related inflammation also warrant testing. Results can guide infection prevention, targeted treatments, and family planning.
Diagnosis
For many, the first step comes when everyday activities start feeling harder due to repeated infections that don’t behave like typical colds. In Mendelian susceptibility to mycobacterial diseases due to complete ISG15 deficiency, doctors look for a pattern of unusual or severe illness from weak mycobacterial germs, especially after the BCG vaccine often given at birth outside the United States. Early and accurate diagnosis can help you plan ahead with confidence. The diagnosis is based on clinical features, targeted immune testing, and genetic tests that confirm changes in the ISG15 gene.
Doctors look for severe or persistent infections from weak mycobacterial germs, such as swollen lymph nodes, skin or bone infections, or illness after BCG vaccination. This pattern raises concern for ISG15 deficiency and similar immune conditions. Features may begin in infancy or early childhood.
A serious reaction after BCG vaccination, like persistent lymph node swelling or widespread infection, is a key red flag. This history often points toward Mendelian susceptibility to mycobacterial diseases due to complete ISG15 deficiency. It helps distinguish the condition from more common causes of infections.
Samples from affected sites (for example, lymph node, skin, or bone) may be checked by culture or PCR to identify mycobacteria. Knowing the exact germ guides treatment and supports the diagnosis. Negative routine tests do not rule out this condition if the clinical pattern fits.
A complete blood count and standard immune panels may be normal or only mildly changed in ISG15 deficiency. Doctors also check for other causes like HIV to narrow the list. ... and other lab tests may help rule out common conditions.
Stages of Mendelian susceptibility to mycobacterial diseases due to complete isg15 deficiency
Mendelian susceptibility to mycobacterial diseases due to complete ISG15 deficiency does not have defined progression stages. The course varies widely and tends to flare with infections or after certain vaccines, rather than moving through predictable steps. Early symptoms of Mendelian susceptibility to mycobacterial diseases due to complete ISG15 deficiency may appear in infancy—sometimes after BCG vaccination—or later with unusually severe or repeated mycobacterial infections, and diagnosis typically relies on your history, an exam, immune studies, and genetic testing of the ISG15 gene. Different tests may be suggested to help clarify what’s driving infections and to guide treatment choices.
Outlook and prognosis
Daily routines often adapt when infections are frequent, especially in early childhood, and that’s often when Mendelian susceptibility to mycobacterial diseases due to complete ISG15 deficiency first comes to light. Many people ask, “What does this mean for my future?”, and the short answer is that risk centers on certain germs: weakened mycobacteria in the BCG vaccine, environmental mycobacteria in soil and water, and sometimes herpes-family viruses. Severe illness is most likely after live BCG vaccination or with heavy exposures; outside of those triggers, many living with ISG15 deficiency have long stretches of good health. Doctors call this the prognosis—a medical word for likely outcomes. Over time, most people gain stability when exposures are reduced and tailored treatments are in place.
Here’s what research and experience suggest about the future. Mortality is mainly linked to overwhelming mycobacterial infection in early life, particularly soon after BCG, but in settings that avoid live mycobacterial vaccines and use prompt antibiotics, survival is generally good. Some people experience repeated lymph node or skin infections, while others notice only mild, occasional illness; neurological issues are uncommon but have been reported in a small subset. Early care can make a real difference, including avoiding live mycobacterial vaccines, using rapid antibiotics for suspected mycobacterial disease, and considering preventive strategies during high-risk periods. With ongoing care, many people maintain typical growth, attend school or work, and lead active lives.
Understanding the prognosis can guide planning and day-to-day choices, like what to do about early symptoms of ISG15 deficiency during cold-and-flu season or before travel. In medical terms, the long-term outlook is often shaped by both genetics and lifestyle, so avoiding specific exposures, keeping vaccines up to date with non-live options, and having a clear plan for fevers or swollen lymph nodes all matter. Genetic testing can sometimes provide more insight into prognosis, including risks for siblings. Talk with your doctor about what your personal outlook might look like, including vaccination plans and what to do if a mycobacterial infection is suspected.
Long-term effects
Living day to day, the long-term picture centers on how repeat infections and inflammation can affect organs over time. Long-term effects vary widely, and not everyone will experience the same issues. People sometimes ask about early symptoms of Mendelian susceptibility to mycobacterial diseases due to complete ISG15 deficiency, but the long-term picture usually reflects repeated mycobacterial infections and how the body heals afterward. Many remain well between infections, yet scarring or organ changes can build up after severe episodes.
Repeat infections with environmental mycobacteria or tuberculosis can occur. Over years, this can leave lasting tissue changes.
After newborn BCG vaccination, local or widespread infection may develop. Some have lingering scarring in the skin or lymph nodes.
Exposure to Mycobacterium tuberculosis can lead to serious disease. Healed areas may leave cavities or scars that persist.
Enlarged, inflamed nodes may drain or scar after infection. Nearby tissues can stiffen or tether due to healing changes.
How is it to live with Mendelian susceptibility to mycobacterial diseases due to complete isg15 deficiency?
Daily life with Mendelian susceptibility to mycobacterial diseases due to complete ISG15 deficiency often revolves around preventing and promptly treating infections, especially from weaker mycobacteria that most people easily clear. For many, that means more frequent clinic visits, careful vaccination planning, quick evaluation of fevers, and sometimes prolonged antibiotic courses, which can interrupt school, work, and travel. Families and close contacts may feel the strain of heightened vigilance and scheduling around medical care, yet clear action plans, infection-prevention habits, and support from immunology and infectious-disease teams can make routines steadier. Many people find that with education, emergency plans, and community support, daily life becomes more predictable and confidence grows over time.
Treatment and drugs
Treatment for Mendelian susceptibility to mycobacterial diseases due to complete ISG15 deficiency focuses on quickly treating infections and preventing new ones. Doctors typically use targeted antibiotics for mycobacterial infections (such as those from BCG vaccine or environmental mycobacteria), often in combinations and for many months, and may add antifungals or antivirals if those infections occur. Preventive steps can include avoiding live mycobacterial vaccines like BCG, considering antibiotic prophylaxis in high‑risk situations, and updating inactivated vaccines to reduce other illness triggers; your doctor can help weigh the pros and cons of each option. In rare cases with severe, recurrent disease despite standard therapy, specialists may discuss interferon‑gamma or hematopoietic stem cell transplant, which are complex treatments reserved for selected people at expert centers. Keep track of how you feel, and share this with your care team.
Non-drug treatment
Living with Mendelian susceptibility to mycobacterial diseases due to complete ISG15 deficiency often means focusing on smart prevention, quick responses to early signs of infection, and steady support for overall health. Beyond prescriptions, supportive therapies can lower infection risk and reduce complications during recovery. Plans usually include practical day‑to‑day steps at home plus guidance from an immunology and infectious disease team. Needs can change with age, so strategies are adjusted over time.
Careful handwashing, wound care, and dental hygiene lower everyday germ exposure. Safe food handling and cooking help reduce risk from undercooked meats or unpasteurized products. Keep routine sick‑day plans for school, work, and travel.
Work with your care team to avoid live vaccines like BCG and consider timing for other immunizations. Household contacts should be fully vaccinated to create a circle of protection. Ask your doctor which non-drug options might be most effective alongside vaccines.
Limit exposure to hot tubs, unchlorinated pools, and aerosolized water where non-tuberculous mycobacteria can thrive. Use well-maintained chlorinated pools and avoid stirring up dust or soil without a mask. Rinse skin after outdoor activities and cover scrapes promptly.
Learn the early symptoms of Mendelian susceptibility to mycobacterial diseases due to complete ISG15 deficiency, such as persistent fevers, swollen lymph nodes, or new drainage near vaccine sites. Have a plan for rapid medical review if signs last more than a couple of days. Keep a simple symptom diary to track patterns.
Your genes may have an impact on how drugs work for you
Your genes can change how well certain antimicrobials, interferon-based therapies, or supportive drugs work, and how likely you are to experience side effects. In ISG15 deficiency, pathways tied to interferon signaling may alter drug response, so treatment is individualized and closely monitored.
Pharmacological treatments
Treatment focuses on two goals: clearing active mycobacterial infections and strengthening the body’s interferon-gamma (IFN-γ) pathway, which is central to fighting these germs in ISG15 deficiency. Doctors tailor drug choices to the specific mycobacterium (BCG vaccine strain, tuberculosis, or environmental species) and to disease severity. Not everyone responds to the same medication in the same way. Care often combines multi-drug antibiotics with immune-boosting therapy and close monitoring for side effects.
Isoniazid, rifampin (or rifabutin), and ethambutol are often used together for BCG or nontuberculous mycobacterial infections. Pyrazinamide is used for tuberculosis but is avoided for BCG disease because BCG is resistant to it. Treatment length is usually many months to ensure full clearance.
Clarithromycin or azithromycin may be added when the infection is caused by nontuberculous mycobacteria like MAC. This add-on helps cover species that respond better to macrolides. Your team will adjust combinations based on culture and drug-susceptibility results.
Interferon gamma-1b (Actimmune) can boost IFN-γ signaling to help immune cells kill mycobacteria. It may be used alongside antibiotics, especially if early symptoms of Mendelian susceptibility to mycobacterial diseases due to complete ISG15 deficiency appeared after BCG vaccination. Dosing and duration are individualized and monitored for flu-like side effects.
Amikacin or streptomycin (injectable), plus a fluoroquinolone such as moxifloxacin or levofloxacin, may be added if disease is extensive or drug-resistant. Linezolid is another option for difficult infections but needs careful blood count and nerve checks. These regimens are usually managed by infectious disease specialists.
Genetic influences
In this condition, harmful changes in both copies of the ISG15 gene are inherited in an autosomal recessive way, meaning a child needs to receive one nonworking copy from each parent. ISG15 helps the immune system mount strong defenses against certain mycobacteria by supporting signals that trigger infection‑fighting responses, especially a key immune messenger called interferon‑gamma. When ISG15 is completely missing or not working, children are more likely to develop severe illness after exposure to the BCG vaccine or environmental mycobacteria; this specific pattern is known as Mendelian susceptibility to mycobacterial diseases due to complete ISG15 deficiency. Parents usually feel well but each may carry one nonworking copy. A “carrier” means you hold the gene change but may not show symptoms. If both parents are carriers, each pregnancy has a 25% (1 in 4) chance of a child inheriting both changes and being affected. Genetic testing for Mendelian susceptibility to mycobacterial diseases due to complete ISG15 deficiency and counseling can confirm the diagnosis in the family and guide decisions about future pregnancies and BCG vaccination.
Is Mendelian susceptibility to mycobacterial diseases due to complete isg15 deficiency genetic?
Genetics are central in this condition; complete ISG15 deficiency is an inherited, single-gene cause. Variants disrupt immune signaling against mycobacteria, driving vulnerability and shaping severity. Family history informs risk, and genetic testing confirms diagnosis and guides counseling.
Pharmacogenetics—how genetics influence drug effects
A confirmed diagnosis of Mendelian susceptibility to mycobacterial diseases due to complete isg15 deficiency helps doctors choose therapies that boost the right immune pathways and avoid others that may not help. In this condition, adding interferon gamma (IFN-γ) to multi-drug antibiotics can be considered because the pathway it targets still works, while some other genetic forms of mycobacterial susceptibility do not respond to IFN-γ. Your care team will also consider longer, combination antibiotic courses and close monitoring to prevent relapse.
How you handle key tuberculosis‑type medicines can also be shaped by your genes. A “slow metabolizer” may process medicine more slowly, raising the risk of isoniazid side effects like liver irritation or numbness, so dosing or monitoring can be adjusted and vitamin B6 is often given. Rare mitochondrial variants can sharply increase the chance of hearing loss from aminoglycoside antibiotics, so if one of these drugs is needed, your team may pick safer alternatives or use extra caution, and pharmacogenetic testing for Mendelian susceptibility to mycobacterial diseases can help guide these choices.
Interactions with other conditions
Living with Mendelian susceptibility to mycobacterial diseases due to complete ISG15 deficiency often intersects with other health issues, especially infections. If someone also has HIV, is taking immune‑suppressing medicines like high‑dose steroids or anti‑TNF drugs, or is undernourished, the risk of severe or widespread mycobacterial illness can rise. Exposure to tuberculosis or receiving the BCG vaccine can lead to infections that are harder to control, so doctors usually plan vaccines and TB prevention carefully in people with ISG15 deficiency. Viral infections are not consistently more severe in this condition, but strong antiviral immune signals can sometimes stir inflammation, and for some, that may worsen neurologic features already linked to the disorder. A condition may “exacerbate” (make worse) symptoms of another, so treating asthma, diabetes, or lung disease well can help lower the chance of complications from chest infections. Ask if any medications for one condition might interfere with treatment for another.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
History
Families and communities once noticed patterns of severe, lingering infections after common childhood vaccines or mild environmental exposures. A cousin recovered from measles but then battled unusual mycobacterial illness; a sibling had repeated hospital stays after a routine BCG shot. Before modern testing, these stories hinted that some children had a hidden, inherited vulnerability.
Throughout history, people have described stubborn skin and lymph node infections that didn’t match the usual course. Doctors documented unusual reactions to mycobacteria that most people clear easily. Early case notes focused on the infections themselves, because the underlying immune problem was invisible. Over time, descriptions became more precise as clinicians recognized a small group of children with otherwise normal health who struggled specifically with mycobacterial germs.
From early theories to modern research, the story of Mendelian susceptibility to mycobacterial diseases due to complete ISG15 deficiency moved from careful bedside observation to gene-level answers. In the 1990s and 2000s, researchers pieced together that these families shared single-gene conditions that disrupted pathways the immune system uses to sense and fight mycobacteria. ISG15 entered the picture when scientists studying antiviral defenses noticed that this tiny protein also supports signals—especially interferon-gamma—that prime white blood cells to control mycobacteria.
Initially understood only through symptoms, later confirmed by genetic testing, complete ISG15 deficiency was identified in children who developed serious illness from BCG vaccination or from environmental nontuberculous mycobacteria. Reports from different regions showed a similar pattern: normal growth and routine infections, but outsized trouble with mycobacteria. Some also had unusual virus responses or inflammatory episodes, which helped researchers see ISG15 as a connector between antiviral and antimycobacterial immunity.
With each decade, laboratory tools sharpened the picture. Functional studies demonstrated that without ISG15, immune cells released less interferon-gamma and killed mycobacteria less effectively. Historical differences highlight why some children were once labeled as having “atypical mycobacterial disease” without a known cause. As genetic sequencing became widely available, clinicians could name the condition, confirm the diagnosis, and tailor care, including cautious vaccine planning and targeted antimycobacterial treatment.
Knowing the condition’s history helps explain today’s approach: listen for family patterns, test the relevant immune pathways, and confirm the gene change. While complete ISG15 deficiency remains uncommon, its recognition grew out of decades of careful observation joined with genetics. This path from bedside clues to molecular understanding continues to guide how early symptoms of Mendelian susceptibility to mycobacterial diseases are recognized and managed.